Accessibility StatementSkip Navigation BEIJING, Sept. 10, 2025 /PRNewswire/ --Â Shineco Inc. (NASDAQ: SISI) ("Shineco"Â or the "Company"), a leading developer of induced pluripotent stem cell (iPSC) technology platforms, today announced that its subsidiary, Fuzhou Meidashan Biotechnology Co., Ltd., has successfully achieved large-scale production of high-purity, highly active free-form soybean phospholipids. This breakthrough was made possible through its proprietary APCC-UF pure physical extraction technol ...